Curanex Pharmaceuticals Inc (CURX)

CIK 2025942 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Curanex Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Sep 4, 20268-K0001493152-26-041546
Aug 17, 20268-K0001493152-26-038764
Aug 14, 202610-Q0001493152-26-038145
Jul 21, 2026S-80001493152-26-034091
Jun 29, 2026DEF 14C0001493152-26-030447
Jun 18, 2026PRE 14C0001493152-26-029388
May 14, 202610-Q0001493152-26-022892
May 14, 20268-K0001493152-26-022898
May 7, 20268-K0001493152-26-021658
Apr 2, 20268-K0001493152-26-014815
Mar 30, 202610-K0001493152-26-013677
Mar 6, 20268-K0001493152-26-009155
Jan 5, 20268-K0001493152-26-000358
Nov 17, 202510-Q0001493152-25-023710
Nov 17, 2025NT 10-Q0001493152-25-023703
Nov 6, 20258-K0001493152-25-021028
Sep 29, 20258-K0001493152-25-015986
Sep 12, 20258-K0001493152-25-013167
Sep 9, 202510-Q0001493152-25-012880
Sep 2, 202530001641172-25-026280
Sep 2, 202530001641172-25-026285
Sep 2, 202530001641172-25-026287
Sep 2, 202530001641172-25-026284
Sep 2, 202530001641172-25-026286
Sep 2, 202530001641172-25-026283